Global Genetic Disease Diagnostic Market Strategic Research Report

Scope of the Report

Hereditary diseases are those caused by changes in genetic material or controlled by disease-causing genes. Hereditary diseases refer to diseases that are determined wholly or partly by genetic factors, usually congenital or acquired. Be like congenital foolish model, much point to (toe), congenital deafness dumb, hemophilia, these hereditary disease decides to come on completely by genetic factor, and just after be born certain time comes on, want to pass a few years sometimes, more than ten years even ability after decades appears apparent symptom.At present, China has adopted a variety of neonatal disease screening technologies for early diagnosis and treatment of children with genetic diseases without clinical symptoms, effectively reducing the disability rate and mortality rate of children, and greatly reducing the serious harm caused by birth defects to families and society. In recent years, with the rapid development of molecular biology and genomics, genetic testing technology has become the gold standard when it comes to most of the hereditary disease diagnosis, especially in the biochemical or enzymatic method can"t make a diagnosis and test results under the condition of not clear, genetic testing is an important means of diagnosis, but in the field of neonatal hereditary disease screening, genetic testing technology is not yet ripe for applications, Gene screening for neonatal deafness has been reported in China.

In China markets, the core manufacturers of genetic disease diagnostic includes BGI Group, Berry Genomics etc and the top 5 companies hold a share over 40%.

This report presents a comprehensive overview of the global Genetic Disease Diagnostic market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Prenatal Diagnosis
• Screening for Single Gene Genetic Disease
• Preimplantation Genetic Testing
• Others

Segment by players, this report covers

• Abbott
• PerkinElmer
• Roche Diagnostics
• Bio Rad
• Thermo Fisher Scientific
• BGI Group
• Berry Genomics
• Da An Gene Co., Ltd.
• Illumina
• CapitalBio Technology

Segment by Application

• Hospital
• Medical Laboratory
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Genetic Disease Diagnostic market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Medical Laboratory, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact